Vantage Financial Partners (Wisconsin)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$452K Hold
420
0.09% 128
2025
Q3
$320K Sell
420
-2
-0.5% -$1.49K 0.07% 155
2025
Q2
$329K Buy
422
+11
+3% +$8.55K 0.08% 140
2025
Q1
$339K Buy
411
+1
+0.2% +$832 0.08% 129
2024
Q4
$317K Sell
410
-5
-1% -$4.14K 0.08% 132
2024
Q3
$367K Hold
415
0.09% 121
2024
Q2
$376K Buy
415
+17
+4% +$13.6K 0.1% 100
2024
Q1
$309K Buy
398
+5
+1% +$3.56K 0.08% 105
2023
Q4
$229K Sell
393
-85
-18% -$49.6K 0.07% 113
2023
Q3
$257K Buy
478
+1
+0.2% +$515 0.1% 66
2023
Q2
$224K Buy
+477
New +$200K 0.08% 74

Other funds holding LLY

Vantage Financial Partners (Wisconsin)'s LLY Position: Q4 2025 in Review

Vantage Financial Partners (Wisconsin) held its Eli Lilly (LLY) position steady in Q4 2025 at 420 shares worth $452K. The position accounts for 0.09% of the portfolio, ranked #128.

Vantage Financial Partners (Wisconsin) first reported a position in LLY in Q2 2023 and has held it in 11 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Vantage Financial Partners (Wisconsin) held 420 shares of Eli Lilly worth $452K as of Q4 2025.
  • Vantage Financial Partners (Wisconsin) left its Eli Lilly share count unchanged in Q4 2025.
  • Eli Lilly made up 0.09% of Vantage Financial Partners (Wisconsin)'s portfolio in Q4 2025, its #128 holding.
  • Vantage Financial Partners (Wisconsin) first reported a position in Eli Lilly in Q2 2023 and has held it in 11 quarters since.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Vantage Financial Partners (Wisconsin)'s 13F filing for Q4 2025, filed 3 Feb 2026.